Sofinnova Capital VII FCPR, 10% Owner at ShockWave Medical, Inc. (SWAV), sold 234,160 shares at $43.02 ($10.1M) on 2020-01-14, disclosed to the SEC on 2020-01-16.
Scheduled sale ($10.1M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.02 | 42,699 | $1.8M | 18.2% |
| 2 | $43.02 | 42,699 | $1.8M | 18.2% |
| 3 | $43.67 | 16,048 | $701K | 6.9% |
| 4 | $43.67 | 16,048 | $701K | 6.9% |
| 5 | $43.06 | 58,333 | $2.5M | 24.9% |
| 6 | $43.06 | 58,333 |
| $2.5M |
| 24.9% |
| Total | $43.13 avg | 234,160 | $10.1M | 100% |
| Filing → |
| SWAV | SELL | 2020-08-14 | $1.5M | — | Filing → |
| SWAV | SELL | 2020-08-10 | $7.3M | — | Filing → |
| SWAV | SELL | 2020-08-05 | $23.0M | — | Filing → |